The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives
Open accessAbstract
Background & aims Iron overload may be carcinogenic. Patients with hereditary hemochromatosis (HH) are reportedly at a 20-200-fold risk of intrahepatic cancer, but the reported risks for nonhepatobiliary cancers are conflicting. The risk of cancer in heterozygous individuals (estimated allele frequency, 1/10 to 1/20) is unknown. This study aimed to better assess these risks. Methods We performed a population-based cohort study of 1847 Swedish patients with HH and 5973 of their first-degree relatives using nationwide, population-based health and census registers. We used standardized incidence ratios (SIRs) as relative risk. Results With 62 liver cancers and 128 nonhepatobiliary cancers, patients with HH were at a 20-fold risk of liver cancer (SIR, 21; 95% confidence interval [CI], 16-22) but an almost unaltered risk of all other cancers (SIR, 1.2; 95% CI, 1.0-1.4), including nonelevated risks for several gastrointestinal tract cancers. At 10 years of follow-up, the absolute risk of liver cancer was 6% among men and 1.5% among women. With 21 liver cancers and 508 nonhepatobiliary cancers, first-degree relatives were at an unaltered risk of extrahepatic cancer (SIR, 1.0; 95% CI, 0.9-1.1, including unelevated risks for gastrointestinal cancers) but at a modest and historic increased risk of hepatobiliary cancer (SIR, 1.5; 95% CI, 1.0-2.4), the histopathologic spectrum of which differed from the patients. Conclusions Patients (particularly men) with HH are at increased risk for hepatocellular cancer, although the magnitude of the risk is lower than previous estimates. Overall cancer risk in first-degree relatives does not seem to be increased.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Murine erythroleukemia cells that overexpress ferritin H displayed lower levels of the labile iron pool and ROS (78).”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [78]
In the citing paper
“Accumulating evidence shows that ferritin acts as an antioxidant protein (59, 60, 78, 159, 227, 243).”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [78]
In the citing paper
“induction of ferritin mRNA was observed in mouse liver (303) and erythroid cells (78) treated with oxidative stress–inducing compounds.”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [78]
In the citing paper
“overexpression or knockdown of ferritin expression in mammalian cells has proven the cytoprotective role of ferritin under prooxidative conditions (59, 60, 78, 159, 227, 243).”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [78]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Survival and Causes of Death in Cirrhotic and in Noncirrhotic Patients with Primary Hemochromatosis
Niederau, C., Fischer, R., Sonnenberg, A., Stremmel, W., Trampisch, H. J., & Strohmeyer, G. W. (1985) · New England Journal of Medicine · doi:10.1056/nejm198511143132004 · Cited by 1,063
Long-term survival in patients with hereditary hemochromatosis
Niederau, C., Fischer, R., Pürschel, A., Stremmel, W., Häussinger, D., & Strohmeyer, G. W. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8613000 · Cited by 885
Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA
Beutler, E., Felitti, V. J., Koziol, J. A., Ho, N. J., & Gelbart, T. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07447-0 · Cited by 823
Prevalence of Hemochromatosis among 11,065 Presumably Healthy Blood Donors
Edwards, C. Q., Griffen, L. M., Goldgar, D. E., Drummond, C., Skolnick, M. H., & Kushner, J. P. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805263182103 · Cited by 628
Body Iron Stores and the Risk of Cancer
Stevens, R. G., Jones, D. Y., Micozzi, M. S., & Taylor, P. R. (1988) · New England Journal of Medicine · doi:10.1056/nejm198810203191603 · Cited by 575
Iron-induced carcinogenesis: The role of redox regulation
Toyokuni, S. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)02111-6 · Cited by 568
Mattsson, B., & Wallgren, A. (1984) · Acta Radiologica Oncology · doi:10.3109/02841868409136026 · Cited by 558
HFE Gene and Hereditary Hemochromatosis: A HuGE Review
Hanson, E. H. (2001) · American Journal of Epidemiology · doi:10.1093/aje/154.3.193 · Cited by 435
Jazwinska, E. C., Cullen, L. M., Busfield, F., Pyper, W. R., Webb, S. I., Powell, L. W., Morris, C. P., & Walsh, T. P. (1996) · Nature Genetics · doi:10.1038/ng1196-249 · Cited by 419
Jouanolle, A. M., Gandon, G., Jézéquel, P., Blayau, M., Campion, M. L., Yaouanq, J., Mosser, J., Fergelot, P., Chauvel, B., Bouric, P., et al. (1996) · Nature Genetics · doi:10.1038/ng1196-251 · Cited by 338
Flagged first, then by citations
Research works printed but not linked: 2
- Tiniakos, 1988, Cirrhotic process, liver cell carcinoma and extrahepatic malignant tumors in idiopathic haemochromatosis, Appl Pathol, 6, 128
- Hulten, 1995, Iron absorption from the whole diet, Eur J Clin Nutr, 49, 794
Cited by
Sorted by citations
Items 201–273 of 273
Hepatocellular Carcinoma in the Middle East: An Overview
Kamal, S. M. (2021) · Springer eBooks · doi:10.1007/978-3-030-78737-0_18 · Cited by 5
Clinical Epidemiology of Chronic Liver Disease: Hepatocellular Carcinoma
Suraweera, D., Konyn, P., Vu, T., & Saab, S. (2018) · Clinical Epidemiology of Chronic Liver Diseases · doi:10.1007/978-3-319-94355-8_15 · Cited by 6
Tenenbein, M., & Huang, X. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822946-0.00016-7 · Cited by 5
Miyamoto, Y., Nakano, S., Ihira, H., Yamaji, T., Katagiri, R., Sawada, N., Inoue, M., Tsugane, S., & Iwasaki, M. (2022) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-22-0151 · Cited by 4
Lee, S.-M., Loguinov, A. V., Fleming, R. E., & Vulpe, C. D. (2014) · Genes & Nutrition · doi:10.1007/s12263-014-0443-1 · Cited by 4
“These shared perturbations could contribute to the pathological conditions found in HH, such as hepatocellular carcinoma (Elmberg et al. 2003; Strohmeyer et al. 1988; Bradbear et al. 1985; Niederau et al. 1985).”
BackgroundUpdate to risk factors for hepatocellular carcinoma
Abdel‐Hamid, N. M. (2009) · International Journal of Medicine and Medical Sciences · doi:10.5897/ijmms.9000252 · Cited by 4
Scandinavian epidemiological research in gastroenterology and hepatology
Bjornsson, E. S., & Ekbom, A. (2015) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2015.1034168 · Cited by 3
“[140] Elmberg M, Hultcrantz R, Ekbom A, Brandt L, Olsson KS,”
BackgroundResultSelf-citationThe Acute Phase Protein Hepcidin Is Cytotoxic to Human and Mouse Myeloma Cells
Conrad, D., Hilchie, A. L., McMillan, K. A. M., Liwski, R., Hoskin, D. W., & Coombs, M. R. P. (2021) · Anticancer Research · doi:10.21873/anticanres.14811 · Cited by 3
Forty years of successful national research collaboration in liver disease – the Swedish experience
Bergquist, A. M., Ekstedt, M., Hagström, H., Järnerot, G., Lindgren, S. C., Nilsson, E., Nyhlin, N., Rorsman, F., Stal, P. I., Werner, M., et al. (2024) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2024.2421824 · Cited by 3
“A slightly increased mortality rate [28] and higher risk of hepatocellular carcinoma [29] were demonstrated in the haemochromatosis cases compared to controls or first-degree relatives, but no increased risk för colorectal or breast cancer. this was later verified in a cohort of 3800 patients with…”
Self-citationMolekulargenetische Analyse und klinische Aspekte bei Patienten mit hereditärer Hämochromatose
Lange, U., Teichmann, J., & Dischereit, G. (2014) · Der Orthopäde · doi:10.1007/s00132-014-2318-y · Cited by 3
Balagtas, J. M. S., & Dahl, G. V. H. (2010) · Pediatric Blood & Cancer · doi:10.1002/pbc.22829 · Cited by 3
“Though the HFE gene has been strongly associated with certain cancers, most notably hepatic malignancies [7], the gene’s association with leukemia is less clear [8,9].”
BackgroundWang, H., Wang, B., Wang, T., & Fan, R. (2020) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2020.01.006 · Cited by 3
Surveillance for Hepatocellular Carcinoma
Corte, C. D., & Colombo, M. G. (2016) · Springer eBooks · doi:10.1007/978-3-319-34214-6_22 · Cited by 3
Surgery for Hepatocellular Carcinoma Arising in Hereditary Hemochromatosis
Sotiropoulos, G. C., Molmenti, E. P., Lang, H., Beckebaum, S., Kaiser, G. M., Brokalaki, E. I., Frilling, A., Malagó, M., Neuhäuser, M., & Broelsch, C. E. (2006) · European Surgical Research · doi:10.1159/000094532 · Cited by 3
“Affected patients have a 20- up to 200-fold increased risk of developing HCC [ ,”
Developing Ligands to Target Transition Metals in Cancer
Utterback, R. D., & Tomat, E. (2019) · Wiley eBooks · doi:10.1002/9781119951438.eibc2694 · Cited by 3
TSAT-Urated Insights: Clarifying the Complexities of Hereditary Hemochromatosis and Its Guidelines
Marcon, C., Medeot, M., Michelazzi, A., Simeon, V., Poz, A., Cmet, S., Fontanini, E., Cussigh, A., Chiozzotto, M., & Barillari, G. (2024) · Hemato · doi:10.3390/hemato5040035 · Cited by 2
“However, Swedish studies have reported no increase in extrahepatic cancer incidence [133,134].”
Epidemiologie, Ätiologie und Pathogenese
Schott, E., Bergk, A., Büchsel, R., Berg, T., Schott, E., Aghdassi, A. A., Weiss, F. U., Mayerle, J., & Lerch, M. M. (2010) · Springer eBooks · doi:10.1007/978-3-642-04935-4_2 · Cited by 2
Bruix, J., Brú, C., & Llovet, J. M. (2006) · Elsevier eBooks · doi:10.1016/b978-1-4160-3258-8.50064-4 · Cited by 2
Papadopoulos, N., & Koskinas, J. S. (2021) · Hepatoma Research · doi:10.20517/2394-5079.2021.118 · Cited by 2
Valenti, L. V. C., Pelusi, S., & Ronzoni, L. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-98368-6.00013-6 · Cited by 2
Hemochromatosis, Wilson's Disease, and Alpha‐1‐Antitrypsin Deficiency
Glass, L. M., & Dickson, R. C. (2016) · doi:10.1002/9781119127437.ch84 · Cited by 2
Benign and Malignant Tumors of the Liver
Sherman, M. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511547416.013 · Cited by 1
McMilin, K. D., & Dasgupta, S. (2007) · Stem Cells and Development · doi:10.1089/scd.2006.0080 · Cited by 1
Atypical Arthritis due to Combined Hereditary Hemochromatosis and Active Hepatitis C
Zafar, S., & Badsha, H. (2008) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0b013e31816373f3 · Cited by 1
“One of the largest population-based studies to address this issue estimated that the risk of developing HCC was increased approximately 20-fold if the individual was suffering from HH, as compared with the general population.(13) The combination of HCV and HH has been proven to increase the progression to liver fibros…”
BackgroundCARCINOMA HEPATOCELULAR – UMA REVISÃO BIBLIOGRÁFICA
Vianna, B. L., Muncinelli, J. F. G., Garcia, R. E., & Tomasich, F. D. S. (2015) · Revista Médica da UFPR · doi:10.5380/rmu.v2i4.44264
Molecular Biology of Liver Carcinogenesis and Hepatitis
KELLY, C. R., & Wands, J. R. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-3256-4.50021-1 · Cited by 1
Heterogeneity of Hepatocellular Carcinoma
Fang, T., Feng, L., & Xia, J. (2016) · Translational bioinformatics · doi:10.1007/978-94-017-7543-4_16 · Cited by 1
Hepatocellular Carcinoma: Epidemiology, Basic Principles of Treatment, and Clinical Data
Singal, A. G., Gopal, P., & Yopp, A. C. (2017) · Springer eBooks · doi:10.1007/978-3-319-54531-8_13 · Cited by 1
Marrero, J. A. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0881-3.00057-7 · Cited by 1
Cunnane, G. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-31696-5.00118-2 · Cited by 1
Carcinome hépatocellulaire : nouveautés épidémiologiques et démarche diagnostique
Blanc, J. (2017) · ONCOLOGIE · doi:10.1007/s10269-017-2709-x · Cited by 1
“(multiplié par 20) [36] avec un rôle carcinogène propre du fer, néanmoins, le dépistage n’est justifié qu’au stade de”
Bergasa, N. V. (2021) · Springer eBooks · doi:10.1007/978-1-4471-4715-2_13 · Cited by 1
Mutaciones del gen HFE y riesgo de carcinoma hepatocelular
Herruzo, J. A. S., & Solís‐Muñoz, P. (2007) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082007000700001 · Cited by 1
Liver, Gallbladder, and Extrahepatic Bile Ducts
Kanel, G. C. (2007) · The Cancer Handbook · doi:10.1002/9780470025079.chap39.pub2 · Cited by 1
Myers, I. (2014) · Cited by 1
Metabolic disorders and storage diseases
Kuntz, E., & Kuntz, H.-D. (2002) · Springer eBooks · doi:10.1007/978-3-662-04680-7_31 · Cited by 1
Tendler, D. A. (2006) · doi:10.1002/9780470751541.ch11 · Cited by 1
Primary Hepatocellular Carcinoma
Dufour, J., & Hora, C. (2010) · Molecular pathology library · doi:10.1007/978-1-4419-7107-4_56
How to Find and Apply Large Databases for Epidemiologic Research
Ludvigsson, J. F., West, J., Davila, J. A., Card, T. R., & El‐Serag, H. B. (2014) · doi:10.1002/9781118727072.ch9
Gestione del carcinoma epatocellulare: le linee guida internazionali
Fenoglio, L. M., Castagna, E., Serraino, C., Cardellicchio, A., Pomero, F., Bracco, C., & Grosso, M. (2009) · Italian Journal of Medicine · doi:10.1016/j.itjm.2008.10.001
Haemochromatosis and non-hepatic malignancy
Limdi, J. K., & Crampton, J. R. (2005) · QJM · doi:10.1093/qjmed/hci062
Management of hepatocellular carcinoma: international guidelines
Fenoglio, L. M., Castagna, E., Serraino, C., Cardellicchio, A., Pomero, F., Bracco, C., & Grosso, M. (2013) · Italian Journal of Medicine · doi:10.4081/itjm.2009.136
Colangiolocarcinoma em doente com hemocromatose hereditária
Marques, M., Cardoso, H., Lopes, J., Carneiro, F., & Macedo, G. (2012) · GE Portuguese Journal of Gastroenterology · doi:10.1016/j.jpg.2012.04.028
Hereditary Hemochromatosis and Iron Overload
Niederau, C. (2009) · Springer eBooks · doi:10.1007/978-3-642-04519-6_28
Hepatocellular Carcinoma Arising in the Non-viral, Non-alcoholic Liver
Woodall, C. E., Martin, R. C. G., McMasters, K. M., & Scoggins, C. R. (2010) · Springer eBooks · doi:10.1007/978-1-60327-522-4_8
Davis, C. F., & Dorak, M. T. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6752-7_17
“, 2007) – Increased hepatic and extra-hepatic cancers in hereditary hemochromatosis patients and their relatives (Ammann et al., 1980; Tiniakos and Williams, 1988; Hsing et al., 1995; Mallory and Kowdley, 2001; Geier et al., 2002; Elmberg et al., 2003) – Correlation between serum iron levels and cancer risk (Stevens e…”
BackgroundHemocromatose associada a carcinoma hepatocelular e neoplasias extra-hepáticas
Cambruzzi, E., Pêgas, K. L., Zettler, C. G., & Ferrari, M. B. (2012)
Iron transport and liver injury in mouse models of hereditary haemochromatosis
De Lima, R. (2013) · UWA Profiles and Research Repository (University of Western Australia)
Hereditary hemochromatosis : with a special emphasis on HFE genotyping
Hannuksela, J. (2004)
Семейный анамнез детей с мутациями наследственного гемохроматоза
Polyakova, S. I. (2010) · CyberLeninK (CyberLeninka)
Jereza, N. A. (2016) · UWE Research Repository (UWE Bristol)
The Prognostic Capability and Molecular Function of Duodenal Cytochrome B in Breast Cancer
Lemler, D. J. (2016) · OpenCommons at University of Connecticut (University of Connecticut)
A series of 7 patients with ankle arthritis, and a review of the literature
Carlsson, Å. (2009)
Does HFE Genotype Impact Macrophage Phenotype in Disease Process and Therapeutic Response?
Nixon, A. M., & Connor, J. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804562-6.00004-x
Immune Regulation in HCC and the Prospect of Immunotherapy
Chakraborty, J., Hilgenfeldt, E., & Cabrera, R. (2017) · Molecular pathology library · doi:10.1007/978-3-319-68082-8_10
Orasan, O. H., Stefan, A., Urian, L. G., Mihailov, A. C., Fabian, O. V., Mureșan, F., Breaban, I., Secara, S., Țărmure, S., Negrean, V., et al. (2018) · Journal of Mind and Medical Sciences · doi:10.22543/7674.52.p300304
Cunnane, G. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4377-1738-9.00118-3
Metabolic disorders and storage diseases
(2006) · Springer eBooks · doi:10.1007/3-540-28977-1_31
Cunnane, G. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3285-4.10108-1
Screening, Surveillance, and Prevention of Hepatocellular Carcinoma
McEneaney, L. J., Vithayathil, M. K., & Khan, S. A. (2024) · Wiley eBooks · doi:10.1002/9781119756422.ch16
Multifocal Hepatocellular Carcinoma in a Malayan Wreathed Hornbill ( Rhyticeros undulatus)
Iyer, M. L., Guzman, D. S.-M., Sosa-Higareda, M., Tarbert, D. K., McLarty, E. M., Herman, A., & Alex, C. E. (2024) · Journal of Avian Medicine and Surgery · doi:10.1647/23-00020
Integrated analysis of hepatocellular carcinoma reveals disparate subtype of prognosis significancePreprint
Jiang, F., Jiang, X., Zhang, Z.-Y., Wang, J., & Liu, J. (2024) · Research Square · doi:10.21203/rs.3.rs-4210755/v1
Tu, B. H., Khalyfa, A. A., Bellizzi, A. M., & Tanaka, T. (2024) · ACG Case Reports Journal · doi:10.14309/crj.0000000000001348
Tumor Growth in Overdrive: Detailing an Aggressive Course of Hepatocellular Carcinoma
Singh, S., Delungahawatta, T., Wolff, M., & Haas, C. J. (2024) · Case Reports in Hepatology · doi:10.1155/2024/4950398
“Other risk factors include environmental toxins [4], lifestyle factors such as excessive consumption of alcohol [5], genetic susceptibility [6, 7], and metabolic syndrome [8].”
BackgroundKobets, T., & Williams, G. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00133-9
Extracellular Fine Fiber-Induced Carcinogenesis and Its Prevention
Toyokuni, S., Maeda, Y. K., Lyu, Q., Mi, D., & Kong, Y. (2025) · Springer eBooks · doi:10.1007/978-981-97-7067-0_1
La, Q. D., Faltas, M., Zavareh, A., Gul, Z., Uzair, U., Kahlam, J. S., Baloch, A., Revuri, N., Bachhu, S., Pryor, F., et al. (2025) · Cureus · doi:10.7759/cureus.85936
“Hereditary hemochromatosis patients have a 20-200 times higher risk of developing HCC than the general population [57].”
Craven-Smith, L., McClements, N., Gomes, D., & Pointon, V. (2025) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-025-00865-6
“GH causes increased cancer risk [25] and iron accumulation can result in mortality [24].”
Ferritin in motion: How systemic iron balance and tumor trafficking shape glioblastoma
Tufano, E., & Connor, J. R. (2026) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2026.189573 · Cited by 1
Villareal, L., Liang, Y., Kwon, Y., Hui, S. T., & Xue, X. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102261
Epigenetic regulation of the hepcidin gene expression in hepatoma cells
Yasuda, A., Hayashi, K., Sakota, S., Kanamori, Y., Shimokawa, F., Murakami, M., & Funaba, M. (2026) · FEBS Journal · doi:10.1111/febs.70645
Metadata
- Authors
- Elmberg, M., Hultcrantz, R., Ekbom, A., Brandt, L., Olsson, S., Olsson, R., Lindgren, S., Lööf, L., Stål, P., Wallerstedt, S., Almer, S., Sandberg-Gertzén, H., & Askling, J.
- Affiliations
- Karolinska University Hospital (SE)
- Sahlgrenska University Hospital (SE)
- Uppsala University Hospital (SE)
- Linköping University Hospital (SE)
- Corresponding author
- Elmberg, Maria
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2003-12
- Volume
- 125
- Issue
- 6
- Pages
- 1733-1741
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2165680505
- Cited by
- 273
- References
- 41
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 14 · 2023: 9 · 2022: 8 · 2021: 14 · 2020: 14 · 2019: 12 · 2018: 8 · 2017: 11 · 2016: 11 · 2015: 8 · 2014: 15 · 2013: 19 · 2012: 17
- FWCI
- 5.11
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- Cancerfonden
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Keywords
- hereditary hemochromatosis, cancer risk, iron overload, hepatocellular carcinoma, liver cancer, gastrointestinal cancer, first-degree relatives, heterozygous carriers, familial cancer risk
- MeSH terms
- Hemochromatosis Protein, Adolescent, Adult, Aged, Aged, 80 and over, Female, Hemochromatosis, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Male, Membrane Proteins, Middle Aged, Mutation, Risk, Histocompatibility Antigens Class I
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
